Lippman Evan — SEC Form 4 filings

SEC reporting owner CIK 2062834. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-05-19 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)EVP, Business Development43 legs · 60,258 sh · $2,162,6587

Form 4 filings — Lippman Evan

FiledFormIssuerReported transactionsSource
2026-08-194TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Sale (S): 18,600 @ $36.57EDGAR
2026-05-184TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 11,841 · Sale (S): 5,746 @ $35.58 · Option exercise (M): 74,008 · Sale (S): 35,912 @ $35.58 · Option exercise (M): 11,841 (derivative) @ $0 · Option exercise (M): 74,008 (derivative) @ $0EDGAR
2026-03-064TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Grant/award (A): 27,347 (derivative) @ $0EDGAR
2025-05-194TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Grant/award (A): 47,365 (derivative) @ $0 · Grant/award (A): 148,016 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2062834 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →